Annual SG&A
$1.46B$327.70M+28.83%
Summary
- Current Value
- As of today, VRTX annual SG&A is $1.46B, up +28.83% on
- Historical Performance
- VRTX annual SG&A is up +74.30% over the past 3 years, and up +122.37% over the past 5 years
- All-Time High Comparison
- VRTX annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- VRTX annual SG&A is +55.00% above its 3-year low of $944.70M reached on an earlier date
- Sector Comparison
- VRTX annual SG&A is higher than 97.54% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $1.46B | +28.8% | +74.3% | +122.4% | +1024.7% | |
| Quarterly SG&A | $445.10M | +19.7% | +80.3% | +141.2% | +811.1% | |
| TTM SG&A | $43.51B | +2889.1% | +4566.5% | +5672.0% | +10000.0% | |
| Price | $460.59 | +11.4% | +53.0% | +102.8% | +1094.8% | |
| Annual Operating Expenses | $5.09B | +18.5% | +30.9% | +111.1% | +648.7% | |
| Annual Operating Profit | $4.40B | +2.0% | +58.1% | +265.6% | +841.4% | |
| Annual D&A | $207.20M | +22.2% | +65.0% | +93.8% | +588.2% | |
| Annual Revenue | $10.98B | +11.6% | +44.5% | +165.9% | +10000.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.46B | at high | |
| 5Y | $1.46B | at high | |
| All | $1.46B | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $944.70M | N/A | +55.0% |
| 5Y | $770.50M | N/A | +90.0% |
| All | $6.40M | >+9999.0% |
SG&A History
FAQ
What is the current annual SG&A of VRTX?
As of today, VRTX annual SG&A is $1.46B
What is 1-year change in VRTX annual SG&A?
VRTX annual SG&A is up +28.83% year-over-year
What is 3-year change in VRTX annual SG&A?
VRTX annual SG&A is up +74.30% over the past 3 years
How far is VRTX annual SG&A from its all-time high?
VRTX annual SG&A is currently at its all-time high
How does VRTX annual SG&A rank versus sector peers?
VRTX annual SG&A is higher than 97.54% of companies in Healthcare sector
When is VRTX next annual earnings release?
The next annual earnings release for VRTX is on
Quarterly SG&A
$445.10M$20.50M+4.83%
Summary
- Current Value
- As of today, VRTX quarterly SG&A is $445.10M, up +4.83% on
- Historical Performance
- VRTX quarterly SG&A is up +19.71% year-over-year, and up +80.35% over the past 3 years
- All-Time High Comparison
- VRTX quarterly SG&A is currently at its all-time high
- 3-Year Low Comparison
- VRTX quarterly SG&A is +84.61% above its 3-year low of $241.10M reached on
- Sector Comparison
- VRTX quarterly SG&A is higher than 96.52% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $445.10M | +4.8% | +19.7% | +80.3% | +141.2% | |
| Annual SG&A | $1.46B | – | +28.8% | +74.3% | +122.4% | |
| TTM SG&A | $43.51B | +2670.9% | +2889.1% | +4566.5% | +5672.0% | |
| Price | $460.59 | +13.1% | +11.4% | +53.0% | +102.8% | |
| Quarterly Operating Expenses | $1.42B | +1.4% | +12.7% | +54.5% | +109.8% | |
| Quarterly Operating Profit | $1.24B | +5.4% | +10.6% | +17.0% | +81.8% | |
| Quarterly D&A | $54.00M | +4.5% | +1.5% | +47.1% | +102.7% | |
| Quarterly Revenue | $3.12B | +4.3% | +12.3% | +37.3% | +101.6% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $445.10M | at high | |
| 3Y | $445.10M | at high | |
| 5Y | $445.10M | at high | |
| All | $445.10M | at high |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $377.60M | N/A | +17.9% |
| 3Y | $241.10M | +84.6% | |
| 5Y | $192.08M | +131.7% | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of VRTX?
As of today, VRTX quarterly SG&A is $445.10M
What is VRTX quarterly SG&A most recent change?
VRTX quarterly SG&A was up +4.83% on September 30, 2025
What is 1-year change in VRTX quarterly SG&A?
VRTX quarterly SG&A is up +19.71% year-over-year
How far is VRTX quarterly SG&A from its all-time high?
VRTX quarterly SG&A is currently at its all-time high
How does VRTX quarterly SG&A rank versus sector peers?
VRTX quarterly SG&A is higher than 96.52% of companies in Healthcare sector
When is VRTX next earnings release?
The next earnings release for VRTX is on
TTM SG&A
$43.51B$3.68B+9.22%
Summary
- Current Value
- As of today, VRTX TTM SG&A is $43.51B, up +9.22% on
- Historical Performance
- VRTX TTM SG&A is up +2889.06% year-over-year, and up +4566.47% over the past 3 years
- All-Time High Comparison
- VRTX TTM SG&A is currently at its all-time high
- 3-Year Low Comparison
- VRTX TTM SG&A is +107.58% above its 3-year low of $20.96B reached on an earlier date
- Sector Comparison
- VRTX TTM SG&A is higher than 97.36% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $43.51B | +2670.9% | +2889.1% | +4566.5% | +5672.0% | |
| Annual SG&A | $1.46B | – | +28.8% | +74.3% | +122.4% | |
| Quarterly SG&A | $445.10M | +4.8% | +19.7% | +80.3% | +141.2% | |
| Price | $460.59 | +13.1% | +11.4% | +53.0% | +102.8% | |
| TTM Operating Profit | $4.49B | +2.7% | +1558.5% | +13.6% | +68.7% | |
| TTM D&A | $200.60M | +0.4% | -3.5% | +39.6% | +88.5% | |
| TTM Revenue | $11.74B | +3.0% | +10.5% | +37.1% | +96.4% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $43.51B | N/A | at high |
| 3Y | $43.51B | N/A | at high |
| 5Y | $43.51B | N/A | at high |
| All | $43.51B | N/A | at high |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $36.20B | N/A | +20.2% |
| 3Y | $20.96B | N/A | +107.6% |
| 5Y | -$550.03M | N/A | +8011.3% |
| All | -$21.45B | N/A | +302.9% |
TTM SG&A History
FAQ
What is the current TTM SG&A of VRTX?
As of today, VRTX TTM SG&A is $43.51B
What is VRTX TTM SG&A most recent change?
VRTX TTM SG&A was up +9.22% on September 30, 2025
What is 1-year change in VRTX TTM SG&A?
VRTX TTM SG&A is up +2889.06% year-over-year
How far is VRTX TTM SG&A from its all-time high?
VRTX TTM SG&A is currently at its all-time high
How does VRTX TTM SG&A rank versus sector peers?
VRTX TTM SG&A is higher than 97.36% of companies in Healthcare sector
When is VRTX next earnings release?
The next earnings release for VRTX is on
Selling, General & Administrative Expenses Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- VRTX Official Website www.vrtx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/875320/000087532025000232/0000875320-25-000232-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532025000053/0000875320-25-000053-index.htm
- VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
- VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx